July 20, 2012 — The European equivalent of the US Food and Drug Administration (FDA) yesterday recommended withdrawing ... nasal spray — indicated for treating osteoporosis in the European Union — because of an increased risk for cancer. The European Medicines Agency (EMA) also said that the long-term use of ...-containing medicines delivered by injection or infusion increases the risk for cancer. As a consequence, the EMA...